drugset / Trial / NCT05079620

Early Antibiotics After Aspiration in ICU Patients

NCT05079620 ↗

Phase 4 Terminated 5 enrolled UConn Health
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the use of early antibiotics in ICU patients who appear to have aspirated, to help determine whether this improves outcomes by reducing the later incidence of pneumonia and other negative consequences.

Timeline

Start
2021-11-30
Primary completion
2024-04-12
Completion
2024-04-12

Outcome

Outcome not reported

Stopped (Enrollment): “Under-enrollment”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin clavulanic acid Unknown 875 mg Oral
Subject Cefepime Small molecule 2 g Intravenous
Subject Ceftriaxone Other / unclassified 2 g Intravenous
Subject Levofloxacin Small molecule 750 mg Oral
Subject Vancomycin Other / unclassified — Intravenous